Šiltas medis, UAB - company info and details

Company age: 11 y. 7 mo.

Update

Company overview

Company name Šiltas medis, UAB
Company code 303832877
VAT code LT100009317319
Registered address Kauno r. sav., Zapyškio sen., Jadagonių k., Žibučių g. 7, LT-53403
Registration date 2015-03-04 Company age: 11 y. 7 mo.
Phone Phone
Email Email
Company manager For registered members only Log in
Revenue (2025) 40,270 € +174% History
Profit (2025) -10,867 € History
Share capital 2,500 €
Number of employees 1 History
Managed vehicles 3 List
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Private Limited Liability Company
NACE activity New construction
Ownership form Private without foreign capital

Description

This description was generated by artificial intelligence.
Šiltas medis, UAB (company code 303832877) is an operational private limited liability company registered in 2015. It is a private enterprise in the national private non-financial companies sector, under private ownership, with governance described as CEO only. The company’s main activity is EVRK code F.41.00.10, New construction. It is located in Jadagoniu k., Zapyškio sen., Kauno r. sav., Kauno apskr.

The company remains small in scale and is classified as micro, with average employment at 1 in 2024 and 2025, and 1 so far in 2026. No wage information is provided. Financially, Šiltas medis, UAB generated revenue of EUR 40.3K in 2025, up 174.3% year on year and 35.1% over two years. Despite the stronger turnover, the company continued to post a loss: net profit was EUR -10.9K in 2025, with a profit margin of -27.0%. This followed revenue of EUR 14.7K and a net loss of EUR -25.7K in 2024, compared with EUR 29.8K revenue and a net loss of EUR -12.2K in 2023. Share capital is EUR 2.5K.

Download a detailed company report

Make confident decisions with all the information about Šiltas medis, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report